Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("BUNDY, Brian")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 24 of 24

  • Page / 1
Export

Selection :

  • and

Exact power calculations for detecting hypotheses involving two correlated binary outcomesYU, Jihnhee; KEPNER, James L; BUNDY, Brian N et al.Statistics & probability letters. 2007, Vol 77, Num 3, pp 288-294, issn 0167-7152, 7 p.Article

Intraperitoneal cisplatin and paclitaxel in ovarian cancerARMSTRONG, Deborah K; BUNDY, Brian; WENZEL, Lari et al.The New England journal of medicine. 2006, Vol 354, Num 1, pp 34-43, issn 0028-4793, 10 p.Article

Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of TreatmentORBAN, Tihamer; BUNDY, Brian; MORAN, Antoinette et al.Diabetes care. 2014, Vol 37, Num 4, pp 1069-1075, issn 0149-5992, 7 p.Article

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trialWHERRETT, Diane K; BUNDY, Brian; MONZAVI, Roshanak et al.Lancet (British edition). 2011, Vol 378, Num 9788, pp 319-327, issn 0140-6736, 9 p.Article

AN INTERACTIVE VOICE RESPONSE DIARY FOR PATIENTS WITH NON-DYSTROPHIC MYOTONIASTATLAND, Jeffrey M; YUNXIA WANG; GRIGGS, Robert et al.Muscle & nerve. 2011, Vol 44, Num 1, pp 30-35, issn 0148-639X, 6 p.Article

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trialORBAN, Tihamer; BUNDY, Brian; MORAN, Antoinette et al.Lancet (British edition). 2011, Vol 378, Num 9789, pp 412-419, issn 0140-6736, 8 p.Article

B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year ResultsPESCOVITZ, Mark D; GREENBAUM, Carla J; RODRIGUEZ, Henry et al.Diabetes care. 2014, Vol 37, Num 2, pp 453-459, issn 0149-5992, 7 p.Article

Rituximab Selectively Suppresses Specific Islet AntibodiesLIPING YU; HEROLD, Kevan; KRAUSE-STEINRAUF, Heidi et al.Diabetes (New York, NY). 2011, Vol 60, Num 10, pp 2560-2565, issn 0012-1797, 6 p.Article

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trialsMORAN, Antoinette; BUNDY, Brian; SANDA, Srinath et al.Lancet (British edition). 2013, Vol 381, Num 9881, pp 1905-1915, issn 0140-6736, 11 p.Article

Non-dystrophic myotonia: prospective study of objective and patient reported outcomesTRIVEDI, Jaya R; BUNDY, Brian; GORHAM, Nina et al.Brain. 2013, Vol 136, pp 2189-2200, issn 0006-8950, 12 p., 7Article

Tissue inhibitor of metalloproteinase 1 regulates resistance to infectionLEE, Marie Mei; YOON, Bong-June; OSIEWICZ, Keith et al.Infection and immunity. 2005, Vol 73, Num 1, pp 661-665, issn 0019-9567, 5 p.Article

Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer : A gynecologic oncology group studyBARAKAT, Richard R; BUNDY, Brian N; SPIRTOS, Nick M et al.Journal of clinical oncology. 2006, Vol 24, Num 4, pp 587-592, issn 0732-183X, 6 p.Article

Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patientsGHADERSOHI, Ali; ODUNSI, Kunle; SHAOZENG ZHANG et al.International journal of cancer. 2008, Vol 123, Num 6, pp 1376-1384, issn 0020-7136, 9 p.Article

Gain of 1q Is a Potential Univariate Negative Prognostic Marker for Survival in MedulloblastomaLO, Ken C; CHANGXING MA; BUNDY, Brian N et al.Clinical cancer research. 2007, Vol 13, Num 23, pp 7022-7028, issn 1078-0432, 7 p.Article

Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix : A gynecologic oncology group studyLONG, Harry J; BUNDY, Brian N; GRENDYS, Edward C et al.Journal of clinical oncology. 2005, Vol 23, Num 21, pp 4626-4633, issn 0732-183X, 8 p.Article

Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: A randomized trial of the gynecologic oncology groupVARIA, Mahesh A; STEHMAN, Frederick B; BUNDY, Brian N et al.Journal of clinical oncology. 2003, Vol 21, Num 15, pp 2849-2855, issn 0732-183X, 7 p.Article

Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology GroupsKEYS, Henry M; BUNDY, Brian N; STEHMAN, Frederick B et al.Gynecologic oncology (Print). 2003, Vol 89, Num 3, pp 343-353, issn 0090-8258, 11 p.Conference Paper

Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer : A gynecologic oncology group studyLANCIANO, Rachelle; CALKINS, Alison; BUNDY, Brian N et al.Journal of clinical oncology. 2005, Vol 23, Num 33, pp 8289-8295, issn 0732-183X, 7 p.Article

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma : An Intergroup Study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology GroupMARKMAN, Maurie; BUNDY, Brian N; ALBERTS, David S et al.Journal of clinical oncology. 2001, Vol 19, Num 4, pp 1001-1007, issn 0732-183XArticle

Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlationGRAVES, Tracey D; CHA, Yoon-Hee; HAHN, Angelika F et al.Brain. 2014, Vol 137, pp 1009-1018, issn 0006-8950, 10 p., 4Article

Differential expression of survivin-2B and survivin-ΔEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC)XIANG LING; JIE YANG; DONGFENG TAN et al.Lung cancer. 2005, Vol 49, Num 3, pp 353-361, issn 0169-5002, 9 p.Article

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in Patients with optimally resected stage III ovarian cancer: A gynecologic oncology group studyOZOLS, Robert F; BUNDY, Brian N; GREER, Benjamin E et al.Journal of clinical oncology. 2003, Vol 21, Num 17, pp 3194-3200, issn 0732-183X, 7 p.Article

A QUANTITATIVE MEASURE OF HANDGRIP MYOTONIA IN NON-DYSTROPHIC MYOTONIASTATLAND, Jeffrey M; BUNDY, Brian N; DEWAR, Liz et al.Muscle & nerve. 2012, Vol 46, Num 4, pp 482-489, issn 0148-639X, 8 p.Article

Mexiletine for Symptoms and Signs of Myotonia in Nondystrophic Myotonia: A Randomized Controlled TrialSTATLAND, Jeffrey M; BUNDY, Brian N; MEOLA, Giovanni et al.JAMA, the journal of the American Medical Association. 2012, Vol 308, Num 13, pp 1357-1365, issn 0098-7484, 9 p.Article

  • Page / 1